Thus, the blockade of PD-1–PD-L1 pathway is another feasible strategy to promote the CXCR5+CD8+ T cells function (15, 70), as it has been proved in anti-tumor CD8+ T cells (113, 114). Here, CXCR5 is linked to neoplasm.